# Adversarial review - heterochromatin-aging (2026-10-09 revised edition)

Authoring model: Sol 6.1. Adversarial reviewer: Claude Opus 5.5 (Anthropic). Date: 2026-10-14.

Level before to after: Γ Moderate to Γ Moderate (unchanged).
Findings: 0 Critical, 1 Major (revision-introduced regression), 3 Minor. PMIDs verified 60/60 plus 8 ancillary/erratum records. Claims spot-checked: 10.
Validator (framework/5.4-registry-compatibility): FAIL - 1 fail, 1 warn, 33 pass; **identical on the pre-edit copy**, so the single FAIL (v5.lay_summary, a v5.4-only requirement that a v5.3 review cannot satisfy) and the v5.claim_form phenomenon WARN are pre-existing and untouched by this review.

| # | Severity | Location | Original to corrected | Evidence |
|---|---|---|---|---|
| 1 | **Major - regression** | spliced Consensus provenance section; consensus-addendum.md | "The earlier adversarial approval refers to its original edition" to "No earlier adversarial approval is attached to this case" | No earlier approval exists anywhere for this case; the clause was spliced in unconditionally on 9 October and is absent from the earlier edition. |
| 2 | Minor | Score card final_score.confidence_rationale (x3) | access depth struck as a determinant; band re-derived from evidence quality | Lead policy two-step test. Documented evidence-quality concerns are valid determinants, so Moderate stands rather than rising to High. |
| 3 | Minor | Evidence card [23] | "ErratumIn: PMIDnot supplied." to "Erratum In: PMID not supplied." | Known rendering defect. |
| 4 | Minor | review.md and scorecard.json throughout | ~70 prose and ~260 score-card missing-space defects repaired | Known rendering defect class; Study: PMIDnnnnnnn identifiers left intact. |

Notably **not** findings: the "Best-supported rival" field correctly names the rank-1 non-nominal model, and the REVIEWER-NOTES / Consensus contradiction is absent from this case.

**Divergent copy left untouched:** hsef_v53_popularity_ranks_46_50_2026-10-09/heterochromatin-aging/heterochromatin-aging.review.md.

**Approval:** Following adversarial review and the corrections listed above, the revised document is approved. - Claude Opus 5.5 (Anthropic), 2026-10-14.
